- Home
- CDXS vs VBF Comparison
CDXS vs VBF Comparison
Compare CDXS & VBF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CDXS
- VBF
- Stock Information
- Founded
- CDXS 2002
- VBF 1970
- Country
- CDXS United States
- VBF United States
- Employees
- CDXS N/A
- VBF N/A
- Industry
- CDXS Major Chemicals
- VBF Trusts Except Educational Religious and Charitable
- Sector
- CDXS Industrials
- VBF Finance
- Exchange
- CDXS Nasdaq
- VBF Nasdaq
- Market Cap
- CDXS 201.3M
- VBF 176.7M
- IPO Year
- CDXS 2010
- VBF N/A
- Fundamental
- Price
- CDXS $3.04
- VBF $15.38
- Analyst Decision
- CDXS Buy
- VBF
- Analyst Count
- CDXS 2
- VBF 0
- Target Price
- CDXS $11.00
- VBF N/A
- AVG Volume (30 Days)
- CDXS 910.6K
- VBF 45.5K
- Earning Date
- CDXS 08-07-2025
- VBF 01-01-0001
- Dividend Yield
- CDXS N/A
- VBF 5.18%
- EPS Growth
- CDXS N/A
- VBF N/A
- EPS
- CDXS N/A
- VBF N/A
- Revenue
- CDXS $49,815,000.00
- VBF N/A
- Revenue This Year
- CDXS $12.77
- VBF N/A
- Revenue Next Year
- CDXS $22.12
- VBF N/A
- P/E Ratio
- CDXS N/A
- VBF N/A
- Revenue Growth
- CDXS N/A
- VBF N/A
- 52 Week Low
- CDXS $1.90
- VBF $13.68
- 52 Week High
- CDXS $6.08
- VBF $16.27
- Technical
- Relative Strength Index (RSI)
- CDXS 69.54
- VBF 44.17
- Support Level
- CDXS $2.55
- VBF $15.44
- Resistance Level
- CDXS $2.91
- VBF $15.56
- Average True Range (ATR)
- CDXS 0.20
- VBF 0.12
- MACD
- CDXS 0.06
- VBF -0.01
- Stochastic Oscillator
- CDXS 96.17
- VBF 20.59
About CDXS Codexis Inc.
Codexis Inc is a provider of enzymatic solutions for efficient and scalable therapeutics manufacturing that leverages its proprietary CodeEvolver technology platform to discover, develop, and enhance novel, high-performance enzymes. Codexis enzymes solve challenges associated with small molecule pharmaceuticals manufacturing and nucleic acid synthesis. The Company is currently developing its proprietary ECO Synthesis manufacturing platform to enable the scaled manufacture of RNAi therapeutics through an enzymatic route. Codexis' enzymes can drive improvements such as higher yields, reduced energy usage and waste generation, improved efficiency in manufacturing and greater sensitivity in genomic and diagnostic applications. Geographically, it derives maximum revenue from the Americas.
About VBF Invesco Bond Fund
Invesco Bond Fund is an independent investment management firm. Its investment objective is to seek interest income while conserving capital.